June
The Dispex WhatsApp group isn’t just expert-led, it’s powered by real-world experience from members facing the same challenges as you every day. Throughout June members quickly stepped in to support one another with practical, experience-based answers:
Generic pricing and reimbursement: Members discussed medicines where generic purchase prices exceeded Drug Tariff reimbursement, with Philip sharing guidance to help practices reduce unnecessary losses.
Controlled Drug compliance: When one member asked how to correctly account for an unused Controlled Drug removed from a dosette, members and Philip clarified the correct stock and destruction procedures, ensuring compliance with CD regulations.
Wholesaler discounts and rebates: Members flagged missing AstraZeneca rebate payments and questioned recent discount changes. Philip explained where rebates could now be found and confirmed the latest discount arrangements, helping practices protect dispensing income.
Prescription endorsement queries: Members asked whether GP initials in the margin would be recognised, and whether adding wholesaler details to Ramipril prescriptions could prevent financial losses. The discussion clarified endorsement requirements and highlighted the importance of following DM+D pricing rules.
Practice management and governance: Members sought advice on SOPs for off-site prescription collections, DSQS audit ideas and where to locate wholesaler management reports. Fellow members shared templates, practical workflows and real-life experience to help improve compliance and administration.
You’re not just relying on a few voices from your own practice; you’re tapping into the collective experience of an entire network, ready to help in real time. Plus, you have direct access to experts who can provide further guidance or reference the appropriate authorities whenever required.
Across recent discussions, Philip provided further guidance on protecting dispensing income, explaining changes to wholesaler discount arrangements, identifying where rebate payments could be found, and helping members navigate Controlled Drug legislation and reimbursement challenges.
If you’re not in the group, you’re missing out on free fast peer support and expert-led answers that directly impact your profitability, compliance and confidence!
Click here to join.
